Zymeworks Inc. (ZYME)

Zymeworks Inc. (ZYME $23.95)
- $23.95 Cap: $1.79B
- View ZYME Profile
- View Questions on ZYME

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Zymeworks Inc. (ZYME $23.95)
- $23.95 Cap: $1.79B
- View ZYME Profile
- View Questions on ZYME

Q: What’s your outlook on this stock ?

Read Answer Asked by edward on November 13, 2024

Amgen Inc. (AMGN $343.60)
- $343.60 P/E (TTM): 25.51X Cap: $178.23B
- View AMGN Profile
- View Questions on AMGN
AbbVie Inc. (ABBV $216.15)
- $216.15 P/E (TTM): 163.39X Cap: $382.02B
- View ABBV Profile
- View Questions on ABBV
Honeywell International Inc. (HON $219.17)
- $219.17 P/E (TTM): 23.12X Cap: $136.54B
- View HON Profile
- View Questions on HON
Roper Technologies Inc. (ROP $404.66)
- $404.66 P/E (TTM): 28.66X Cap: $43.45B
- View ROP Profile
- View Questions on ROP
WSP Global Inc. (WSP $268.20)
- $268.20 P/E (TTM): 40.68X Cap: $34.85B
- View WSP Profile
- View Questions on WSP
- View Reports on WSP
Knight Therapeutics Inc. (GUD $5.76)
- $5.76 Cap: $574M
- View GUD Profile
- View Questions on GUD
- View Reports on GUD
Trillium Therapeutics Inc. (TRIL $23.33)
- View TRIL Profile
- View Questions on TRIL
Zymeworks Inc. (ZYME $23.95)
- $23.95 Cap: $1.79B
- View ZYME Profile
- View Questions on ZYME
Jacobs Solutions Inc. (J $138.47)
- $138.47 P/E (TTM): 58.8X Cap: $16.17B
- View J Profile
- View Questions on J

Q: Hey guys,

My health care and industrial sectors are on the low side (under 10%), please provide the top 3 plays (Canadian or American) in each sector. These picks would be going into a "balance" type portfolio.
Thanks
Jim

Read Answer Asked by jim on October 02, 2020

Zymeworks Inc. (ZYME $23.95)
- $23.95 Cap: $1.79B
- View ZYME Profile
- View Questions on ZYME

Q: whats your opinion on zymeworks.i have owned it since 15., its doubled;
its results are strong, they have relationships with 8 of the largest pharma companies. It keeps hitting new 52 week highs. i know they will do a fund raise soon, but got thru the last fund raise with ease. . dave

Read Answer Asked by david on November 25, 2019